Contact
We scope to your needs across our three product lines—with fixed proposals and delivery timelines when scope is clear. Where engagements use the Open Targets Platform (and optional Orange Book or structure-informed layers), narratives stay traceable to public sources and updatable as data changes.
Pricing that fits the boardroom
We structure engagements so decision makers get predictable spend, clear deliverables, and no scope creep. No hourly surprises—you approve a fixed scope, price, and timeline up front when possible.
- Fixed-fee, fixed-timeline — Agreed price and delivery date before work starts (when scope allows).
- Entity-based scoping — Effort scales transparently with targets, diseases, drugs, or programs.
- Product line — Scoped as Portfolio Intelligence, Visibility & Narrative, or Strategic Capital Options (see What we do).
How we scope
Fees and timeline follow your offer and entities. Open Targets–centric work traces to the Platform; Orange Book and structure-informed layers add scoped pulls under Portfolio Intelligence—see Structure-informed diligence.
| Scope input | What we need | Typical use |
|---|---|---|
| Offer | Portfolio Intelligence, Visibility & Narrative, or Strategic Capital Options | Routes method and artifact |
| Target | Per target (e.g. Ensembl ID) | Single-target or multi-target intelligence |
| Disease / indication | Per disease or indication set (e.g. EFO ID) | Landscape, prioritisation |
| Drug | Per drug or drug set | Competitive or mechanism context |
| Portfolio | N targets and/or N diseases | Pipeline or portfolio review |
| Orange Book layer | Approved products / comparators (search scope, date) | Precedent vs listed drugs |
| Structure-informed layer | Sequences / FASTA, monomer vs multimer | Computational structural hypotheses — Structure-informed diligence |
Bundle examples: Open Targets–only Portfolio Intelligence; Open Targets + Orange Book; Open Targets + Orange Book + structure-informed—one proposal, one synthesis.
Get in touch
Email: john@bioticabio.com
Next step
A short call to align on offer, decision question, and entities—then a written proposal with price and timeline.
Before reaching out: Portfolio Intelligence System and methodology.
Operator background · Diligence memo framework (legacy)
Our assessments are for strategic and due-diligence use only; they do not constitute regulatory, medical, or investment advice.
We use your contact details only to respond and do not share them with third parties.